• Io Sapsai 🌱@lemm.ee
    link
    fedilink
    arrow-up
    0
    ·
    7 months ago

    1000$? It costs 80$ here. Insurance covers the 1mg injection completely. Drug prices on the US market are inflated as hell. Also it can be made for 5 bucks but the decades of research and billions poured into said research and testing is what raises the price.

    Regardless corporate greed is corporate greed and big pharma is into some really shady stuff. Especially when we get to biologicals.

    • The_v@lemmy.world
      link
      fedilink
      arrow-up
      1
      ·
      7 months ago

      In a research driven company, research is a basic operational cost. These are all sunk cost paid for by other products. Before the product is introduced all of the research has been paid for.

      So let’s take a look at this companies financials.

      https://finance.yahoo.com/quote/NVO/financials?guccounter=1

      Their cost of goods was 36 billion. Out of 232 billion in sales or around a 85% margin.

      It says they spent 32 billion dollars research.

      They claimed a profit of 104 billion dollars after spending 2x the total research bill on sales/marketing and admin (62 billion) in other research driven industries this would be around 1/2 research budget.

      They still made enough money to pay for more than 3 years of research.

      In better regulated industry where greed didn’t rule the day. They should be making less than 1/2 the gross income.

      This is pure greed based upon people’s suffering

    • GBU_28@lemm.ee
      link
      fedilink
      English
      arrow-up
      0
      ·
      edit-2
      7 months ago

      It costs a 1000. Government programs make it 80. And that’s good.

      • Io Sapsai 🌱@lemm.ee
        link
        fedilink
        arrow-up
        1
        ·
        7 months ago

        Our insurance system IS the government program. The government negotiates prices with the manufacturer. This is also the reason we have drug shortages. Cheaper drugs get re-exported legally by third parties to countries with higher prices. Abbvie straight up made a system where their new drugs would be delivered personally to the individual patient via a personal code to circumvent what happened to Humira.

        Tresiba, Insulatard, Actrapid and a couple of other insulins, as well as antibiotics like Augmentin (which is in short supply to begin with) also suffered from re-export until the government issued a temporary ban.

        The wholesale companies’ response? Stockpile and wait for the ban to expire.